Search Results 1801-1810 of 2911 for site:slotspk17.com

  1. INdependence Through Endovascular Neuroprosthetic Technology (INTENT): An Early Feasibility Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Study To Evaluate The Safety, Tolerability And Preliminary Antitumor Activity Of INCB059872 In Patients With Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of INCB059872 in participants with Ewing sarcoma who are refractory or ...

  3. Study Of Orally Administered MOMA-341 In Participants With Advanced Or Metastatic Solid Tumors - Mayo Clinic

    About this study. This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, ...

  4. A Phase 3 Randomized Clinical Trial To Investigate The Safety And Efficacy Of Palopegteriparatide At Doses Greater Than 30 Μg/Day In Adult Participants With Hypoparathyroidism - Mayo Clinic

    About this study. This trial has a duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or ...

  5. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...

  6. A Phase 1 Trial Of MK-4280 As Monotherapy And In Combination With Pembrolizumab With Or Without Chemotherapy Or Lenvatinib (E7080/MK 7902) In Subjects With Advanced Solid Tumors - Mayo Clinic

    This is a safety and pharmacokinetics study of MK-4280 as monotherapy and in combination with pembrolizumab (MK-3475) in adults with metastatic solid tumors for ...

  7. A Study Of Doxorubicin Plus Olaratumab (LY3012207) In Participants With Advanced Or Metastatic Soft Tissue Sarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study To Evaluate Pembrolizumab Combined With Intensive Chemotherapy To Treat Patients With Acute Myeloid Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the ...

  9. A Study Of Clopidogrel For The Prevention Of TIA And Minor Ischemic Stroke - Mayo Clinic

    The purpose of this study is to assess the effectiveness of Clopidogrel for preventing the occurance of transient ischemic attacks (TIA) and minor strokes.

  10. A Study Evaluating AMG 424 In Subjects With Multiple Myeloma - Mayo Clinic

    Although low level CD38 expression is widespread in different tissue types, including hematopoietic cells, plasma cells express CD38 protein at signficantly ...